2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Neoplasms
3217
Carcinoma, Non-Small-Cell Lung
2731
Breast Neoplasms
2553
Colorectal Neoplasms
1464
Prostatic Neoplasms
1310
Neoplasm Metastasis
1302
Multiple Myeloma
1112
Melanoma
1102
Ovarian Neoplasms
1006
Lung Neoplasms
946
Recurrence
924
Leukemia, Myeloid, Acute
878
Pancreatic Neoplasms
833
Lymphoma, Non-Hodgkin
767
Lymphoma
713
Stomach Neoplasms
693
Carcinoma, Renal Cell
661
Carcinoma, Hepatocellular
648
Leukemia, Lymphocytic, Chronic, B-Cell
560
Squamous Cell Carcinoma of Head and Neck
550
Lymphoma, Follicular
516
Head and Neck Neoplasms
491
Glioblastoma
473
Small Cell Lung Carcinoma
447
Lymphoma, Large B-Cell, Diffuse
440
Triple Negative Breast Neoplasms
436
Advanced Solid Tumors
433
Leukemia
426
Uterine Cervical Neoplasms
420
Urinary Bladder Neoplasms
405
Interventions
BIVV001
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Coagulation Protein Disorders
×
Clear all
NCT06716814
2026-04-20
LIBERTY
Swedish Orphan Biovitrum
Phase 3
Recruiting
104 enrolled